Two Cells Overview
- Founded
-
2003
- Status
-
Private
- Latest Deal Type
-
2ndary - Private
- Investors
-
11
Two Cells General Information
Description
Developer of regenerative medicine designed to regenerate tissues and organs that cannot be regenerated naturally. The company's medicine uses mesenchymal stem cells which is a treatment method in which MSC is taken out, increased in number outside the body, and transplanted into the patient's body, enabling patients to select new treatment methods through the spread of regenerative medicine.
Contact Information
Website
www.twocells.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- 11th floor Hiroshima Industrial Culture Center
- 16-35 Hijiyamahonmachi, Minami-ku
- Hiroshima, 732-0816
- Japan
+81 000-000-0000
Two Cells Timeline
Two Cells Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Secondary Transaction - Private | 01-Dec-2022 | 000.00 | Completed | Clinical Trials - Phase 3 | ||
| 5. Later Stage VC | 26-Nov-2021 | 000.00 | 000.00 | 00000 | Completed | Clinical Trials - Phase 3 |
| 4. Later Stage VC | 23-Dec-2020 | 00.000 | 000.00 | Completed | Clinical Trials - Phase 3 | |
| 3. Later Stage VC | 20-Nov-2019 | 000.00 | 000.00 | Completed | Clinical Trials - Phase 3 | |
| 2. Later Stage VC | 06-Jul-2017 | $5.92M | $8.26M | Completed | Clinical Trials - Phase 3 | |
| 1. Seed Round | 31-May-2016 | $2.34M | $2.34M | Completed | Clinical Trials - Phase 3 |
Two Cells Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| A Preferred | 0,000,000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Two Cells Patents
Two Cells Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2021337035-A1 | Composition for treating central nervous system diseases, method for producing composition for treating central nervous system diseases, and method for producing therapeutic formulation for central nervous system diseases | Pending | 03-Sep-2020 | ||
| AU-2020354743-A1 | Method for manufacturing repairing agent for biological tissue damage, and repairing agent for biological tissue damage | Pending | 26-Sep-2019 | 000000000 | |
| EP-4035670-A1 | Method for manufacturing repairing agent for biological tissue damage, and repairing agent for biological tissue damage | Pending | 26-Sep-2019 | 000000000 | |
| US-20220331366-A1 | Method for manufacturing repairing agent for biological tissue damage, and repairing agent for biological tissue damage | Pending | 26-Sep-2019 | 000000000 | |
| JP-7064251-B2 | A method for heating a biological sample, a heating container for a biological sample, and a kit for heating the biological sample. | Active | 28-Jun-2018 | C12M41/18 | 0 |
Two Cells Executive Team (12)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Toshiki Hiura | President and Chief Executive Officer | ||
| Aki Ohmori | Inventor | ||
| Jin Shao | Inventor | ||
| Ken Innami | Inventor | ||
| Masato Takao | Inventor |
Two Cells Board Members (5)
| Name | Representing | Role | Since |
|---|---|---|---|
| Fumiko Higashikawa | Two Cells | Audit & Supervisory Board Member | 000 0000 |
| Koichiro Tsuji | Two Cells | Executive Chairman | 000 0000 |
| Masahiro Yasuda | Self | Audit & Supervisory Board Member | 000 0000 |
| Shinji Kawauchi | Two Cells | Audit & Supervisory Board Member | 000 0000 |
| Yuichi Murakami | Self | Audit & Supervisory Board Member | 000 0000 |
Two Cells Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Hiroshima Capital Partners | Growth/Expansion | Majority | 000 0000 | 000000 0 | |
| Hiroshima Innovation Network | PE/Buyout | Minority | 000 0000 | 000000 0 | |
| Iyogin Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
| JGC Holdings Corporation | Holding Company | Minority | 000 0000 | 000000 0 | |
| FFG Venture Business Partners | Venture Capital | Minority | 000 0000 | 000000 0 |